Last reviewed · How we verify
NCT04118023
7T MRI to Evaluate Cartilage Defects in the Knee
trial testing 7 Tesla Magnetic Resonance Imaging Test in Cartilage Injury in 112 participants. Completed in 7 September 2022.
19 August 2021
Quick facts
| Lead sponsor | The Methodist Hospital Research Institute |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 112 |
| Start date | 7 October 2019 |
| Primary completion | 19 August 2021 |
| Estimated completion | 7 September 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 7 Tesla Magnetic Resonance Imaging Test
Conditions studied
- Cartilage Injury — all drugs for Cartilage Injury →
- Knee Injuries — all drugs for Knee Injuries →
- Arthropathy of Knee — all drugs for Arthropathy of Knee →
- Cartilage Damage — all drugs for Cartilage Damage →
Sponsor
The Methodist Hospital Research Institute
Who can join
18 and older, any sex, with Cartilage Injury or Knee Injuries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators propose to prospectively evaluate the accuracy of a novel 7-Tesla (7T) knee MRI protocol for the detection and grading of cartilage lesions in the knee, which is a significant limitation of current MRI techniques.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04118023
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cartilage Injury
Currently open trials in the same condition.
- NCT06082531 — Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis · NA · recruiting
- NCT04184687 — The Treatment of Cartilaginous Lesions and Concomitant Anterior Cruciate Ligament Reconstruction · NA · recruiting
- NCT03873545 — Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella · active not recruiting
Other The Methodist Hospital Research Institute trials
Trials by the same sponsor.
- NCT07048314 — Stem Cells for Erectile Dysfunction Post RALP · Phase 1, PHASE2 · not yet recruiting
- NCT07283068 — IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA · NA · not yet recruiting
- NCT07218484 — VoiceLove Digital Therapy for Delirium in the ICU · NA · recruiting
- NCT07050771 — Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery · Phase 2 · recruiting
- NCT07182279 — Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04118023 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Methodist Hospital Research Institute
- Last refreshed: 7 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04118023.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing